Advancing Clinical Research during an Epidemic Meeting, September 2018

Conducting effective clinical trials is no easy task but conducting one during an epidemic is fraught with challenges. GloPID-R and PREPARE are joining forces to bring the scientific community together to discuss the bottlenecks and the associated solutions to rapidly deploying clinical research during an infectious disease outbreak this September 20-21, 2018 in Brussels, Belgium.

This event will host some of the world’s eminent scientists and policymakers to present, discuss and debate the pressing issues surrounding clinical trials. Some of the notable speakers will be: Professor Dame Sally Davies, Dr. Illaria Capua, Professor Mario Monti, Dr. Nicole Lurie, Dr. Herman Goossens, and Dr. John Amuasi.

These leading experts will be to highlight the vital role of clinical research in an infectious disease (ID) epidemic or pandemic. They will also illustrate the fundamental role of working in partnership with patients and the communities. Some other topics include:

  • Highlight the value of combining antimicrobial (AMR) clinical research with ID pandemic preparedness
  • Show how regulators can ensure robust yet expedient review of clinical study protocols
  • Demonstrate the value of novel clinical trial designs to evaluate therapeutic interventions

This meeting is open to anyone involved in outbreak preparedness from the scientific community to public health officials. Registration is now open.


The Platform for European Preparedness Against (Re-)emerging Epidemics (PREPARE) is a member of GloPID-R’s Clinical Trial Networks working group. It is building Europe’s capacity to do clinical research under the inevitable circumstances of an infectious disease epidemic or pandemic.

EU Flag

The GloPID-R Secretariat is a project which receives funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101094188.